Synopsis
0
CEP/COS
0
EU WC
0
NDC API
0
VMF
0
FDF
0
FDA Orange Book
0
Canada
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]JDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]KDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API Imports and Exports
Upgrade, download data, analyse, strategize, subscribe with us 
INTERMEDIATES SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Europe
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
Global Sales Information
Finished Drug Prices
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Market Place
APIs
Reply
15 Jun 2023
Reply
29 Jun 2022
Reply
18 May 2022
Reply
26 Jul 2021
Reply
26 May 2018
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
ABOUT THIS PAGE
A Nadifloxacin manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Nadifloxacin, including repackagers and relabelers. The FDA regulates Nadifloxacin manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Nadifloxacin API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Nadifloxacin manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Nadifloxacin supplier is an individual or a company that provides Nadifloxacin active pharmaceutical ingredient (API) or Nadifloxacin finished formulations upon request. The Nadifloxacin suppliers may include Nadifloxacin API manufacturers, exporters, distributors and traders.
click here to find a list of Nadifloxacin suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Nadifloxacin DMF (Drug Master File) is a document detailing the whole manufacturing process of Nadifloxacin active pharmaceutical ingredient (API) in detail. Different forms of Nadifloxacin DMFs exist exist since differing nations have different regulations, such as Nadifloxacin USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Nadifloxacin DMF submitted to regulatory agencies in the US is known as a USDMF. Nadifloxacin USDMF includes data on Nadifloxacin's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Nadifloxacin USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Nadifloxacin suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Nadifloxacin Drug Master File in Japan (Nadifloxacin JDMF) empowers Nadifloxacin API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Nadifloxacin JDMF during the approval evaluation for pharmaceutical products. At the time of Nadifloxacin JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Nadifloxacin suppliers with JDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Nadifloxacin Drug Master File in Korea (Nadifloxacin KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Nadifloxacin. The MFDS reviews the Nadifloxacin KDMF as part of the drug registration process and uses the information provided in the Nadifloxacin KDMF to evaluate the safety and efficacy of the drug.
After submitting a Nadifloxacin KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Nadifloxacin API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Nadifloxacin suppliers with KDMF on PharmaCompass.
Nadifloxacin Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Nadifloxacin GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Nadifloxacin GMP manufacturer or Nadifloxacin GMP API supplier for your needs.
A Nadifloxacin CoA (Certificate of Analysis) is a formal document that attests to Nadifloxacin's compliance with Nadifloxacin specifications and serves as a tool for batch-level quality control.
Nadifloxacin CoA mostly includes findings from lab analyses of a specific batch. For each Nadifloxacin CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Nadifloxacin may be tested according to a variety of international standards, such as European Pharmacopoeia (Nadifloxacin EP), Nadifloxacin JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Nadifloxacin USP).
LOOKING FOR A SUPPLIER?
Comment (1)
